Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.
Fresenius SE & Co KGaA'in temel mali tabloları nelerdir?
Son mali tabloya (Form-10K) göre, Fresenius SE & Co KGaA'in toplam varlıkları $0 olup, net 이익 $1,264'dir.
FSNUF'ün temel finansal oranları nelerdir?
Fresenius SE & Co KGaA'in cari oranı 0, net kâr marjı 5.52, hisse başına satış $40.53'dir.
Fresenius SE & Co KGaA'in geliri segment veya coğrafya bazında nasıl dağılıyor?
Fresenius SE & Co KGaA 주요 수익원은 Fresenius Kabi이며, 최신 수익 발표에서 수익은 8,612,000,000입니다. 지역별로는 North America이 Fresenius SE & Co KGaA의 주요 시장이며, 수익은 2,701,000,000입니다.
Fresenius SE & Co KGaA kârlı mı?
예, son mali tablolara göre Fresenius SE & Co KGaA'in net 이익 $1,264'dir.
Fresenius SE & Co KGaA'in herhangi bir yükümlülüğü var mı?
no, Fresenius SE & Co KGaA'in yükümlülüğü 0'dir.
Fresenius SE & Co KGaA'in tedavüldeki hisse sayısı kaçtır?
Fresenius SE & Co KGaA'in toplam tedavüldeki hisse sayısı 0'dir.